Literature DB >> 10982057

Predictors for the development of haemolytic uraemic syndrome with Escherichia coli O157:H7 infections: with focus on the day of illness.

K Ikeda1, O Ida, K Kimoto, T Takatorige, N Nakanishi, K Tatara.   

Abstract

A large outbreak of Escherichia coli O157 infections via school lunches occurred at primary schools in 1996 in Sakai City, Japan. As many as 10,000 patients suffered from diarrhoea, haemorrhagic colitis and haemolytic uraemic syndrome (HUS). Using data on 288 inpatient school children affected by this outbreak, of whom 36 presented complete HUS and the remaining 252 tested positive for E. coli O157 culture, we attempted to identify predictors for the progression to HUS. Within the first 5 days of illness, clinical features associated with inpatients who developed HUS compared with those without HUS included a C reactive protein (CRP) level higher than 1.2 mg/dl (OR 44.26; 95% CI 5.83-336.23), a white blood cell (WBC) count greater than 11.0 x 10(9)/l (OR 5.03; 95% CI 2.13-11.87) and a temperature higher than 38.0 degrees C (OR 5.00; 95% CI 2.25-11.08). It can be concluded that these three factors are predictive factors for the development of HUS in patients with E. coli O157 infection, and patients who have two or all of these factors should be observed closely.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10982057      PMCID: PMC2810919          DOI: 10.1017/s0950268899003945

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  9 in total

Review 1.  Leukocytosis as a predictor for progression to haemolytic uraemic syndrome in Escherichia coli O157:H7 infection.

Authors:  M A Anjay; P Anoop; A Britland
Journal:  Arch Dis Child       Date:  2007-09       Impact factor: 3.791

Review 2.  Chronic sequelae of E. coli O157: systematic review and meta-analysis of the proportion of E. coli O157 cases that develop chronic sequelae.

Authors:  Jessica Keithlin; Jan Sargeant; M Kate Thomas; Aamir Fazil
Journal:  Foodborne Pathog Dis       Date:  2013-11-27       Impact factor: 3.171

3.  Gene cluster conferring streptomycin, sulfonamide, and tetracycline resistance in Escherichia coli O157:H7 phage types 23, 45, and 67.

Authors:  K Ziebell; R P Johnson; A M Kropinski; R Reid-Smith; R Ahmed; V P Gannon; M Gilmour; P Boerlin
Journal:  Appl Environ Microbiol       Date:  2011-01-14       Impact factor: 4.792

4.  Differential virulence of clinical and bovine-biased enterohemorrhagic Escherichia coli O157:H7 genotypes in piglet and Dutch belted rabbit models.

Authors:  Smriti Shringi; Alexis García; Kevin K Lahmers; Kathleen A Potter; Sureshkumar Muthupalani; Alton G Swennes; Carolyn J Hovde; Douglas R Call; James G Fox; Thomas E Besser
Journal:  Infect Immun       Date:  2011-10-24       Impact factor: 3.441

5.  Hemolytic-uremic syndrome in Switzerland: a nationwide surveillance 1997-2003.

Authors:  Alexandra Schifferli; Rodo O von Vigier; Matteo Fontana; Giuseppina Spartà; Hans Schmid; Mario G Bianchetti; Christoph Rudin
Journal:  Eur J Pediatr       Date:  2009-10-15       Impact factor: 3.183

6.  Hemolytic uremic syndrome risk and Escherichia coli O157:H7.

Authors:  Boldtsetseg Tserenpuntsag; Hwa-Gan Chang; Perry F Smith; Dale L Morse
Journal:  Emerg Infect Dis       Date:  2005-12       Impact factor: 6.883

7.  Hemolytic uremic syndrome incidence in New York.

Authors:  Hwa-Gan H Chang; Boldtsetseg Tserenpuntsag; Marilyn Kacica; Perry F Smith; Dale L Morse
Journal:  Emerg Infect Dis       Date:  2004-05       Impact factor: 6.883

Review 8.  Management of hemolytic-uremic syndrome in children.

Authors:  Silviu Grisaru
Journal:  Int J Nephrol Renovasc Dis       Date:  2014-06-12

Review 9.  Shiga Toxin-Associated Hemolytic Uremic Syndrome: A Narrative Review.

Authors:  Adrien Joseph; Aurélie Cointe; Patricia Mariani Kurkdjian; Cédric Rafat; Alexandre Hertig
Journal:  Toxins (Basel)       Date:  2020-01-21       Impact factor: 4.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.